IL Dong Pharmaceutical일동제약
249420 · KOSPI · ₩249420 · 일동제약
₩12,790▲ ₩140 (1.11%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 39.6% | 38.8% | 38.0% | 35.6% | 37.1% | 39.2% |
| Operating margin | 4.4% | 3.4% | 2.1% | −9.0% | −11.5% | −9.9% |
| Net margin | 7.5% | 4.9% | −0.7% | −13.1% | −22.2% | −17.8% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +2.7% | −7.8% | +2.4% | −5.8% | +13.9% | — |
| Operating income growth | +32.9% | +48.5% | +124.3% | +26.6% | −32.3% | — |
| Net income growth | +57.6% | +704.5% | +94.2% | +44.3% | −42.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 17.3% | 13.6% | −2.8% | −43.8% | −82.3% | −65.2% |
| Return on assets | 5.8% | 4.1% | −2.1% | −12.8% | −20.8% | −14.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 124.6% | 139.2% | 270.3% | 250.8% | 230.8% | 341.5% |
| Net debt to equity | 25.2% | 25.0% | 88.7% | — | 105.8% | 135.8% |
| Current ratio | 100.3% | 96.1% | 89.5% | 75.0% | 89.2% | 82.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: IL Dong Pharmaceutical / 일동제약 / 249420 / KRX:249420
Source: KRX statistical information